Evidence map›Paper›PMID 33521866›Full record

ReviewDrug delivery and translational research2021

Asymmetric flow field-flow fractionation as a multifunctional technique for the characterization of polymeric nanocarriers.

Federico Quattrini, Germán Berrecoso, José Crecente-Campo, María José Alonso

Erratum issuedAbstract readReview
In one paragraph

Review in Drug delivery and translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. The RNA delivery dilemma-lipid versus polymer nanoparticle platforms.Drug delivery and translational research · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. AdvancingACS bio & med chem Au · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Federico QuattriniCenter for Research in Molecular Medicine and Chronic Diseases, Singular Research Centers, 15782, Santiago de Compostela, Spain.
Germán BerrecosoCenter for Research in Molecular Medicine and Chronic Diseases, Singular Research Centers, 15782, Santiago de Compostela, Spain.
José Crecente-CampoCenter for Research in Molecular Medicine and Chronic Diseases, Singular Research Centers, 15782, Santiago de Compostela, Spain. jose.crecente@usc.es.
María José AlonsoCenter for Research in Molecular Medicine and Chronic Diseases, Singular Research Centers, 15782, Santiago de Compostela, Spain. mariaj.alonso@usc.es.ORCID 0000-0001-7187-9567

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The importance of polymeric nanocarriers in the field of drug delivery is ever-increasing, and the accurate characterization of their properties is paramount to understand and predict their behavior. Asymmetric flow field-flow fractionation (AF4) is a fractionation technique that has gained considerable attention for its gentle separation conditions, broad working range, and versatility. AF4 can be hyphenated to a plurality of concentration and size detectors, thus permitting the analysis of the multifunctionality of nanomaterials. Despite this potential, the practical information that can be retrieved by AF4 and its possible applications are still rather unfamiliar to the pharmaceutical scientist. This review was conceived as a primer that clearly states the "do's and don'ts" about AF4 applied to the characterization of polymeric nanocarriers. Aside from size characterization, AF4 can be beneficial during formulation optimization, for drug loading and drug release determination and for the study of interactions among biomaterials. It will focus mainly on the advances made in the last 5 years, as well as indicating the problematics on the consensus, which have not been reached yet. Methodological recommendations for several case studies will be also included.

Indexed as

Fractionation, Field FlowPharmaceutical PreparationsDrug Delivery SystemsDrug LiberationParticle SizePolymersPharmaceutical PreparationsPolymersAsymmetric flow field-flow fractionationBiocoronaDrug deliveryMultiangle light scatteringPolymeric nanoparticles

Identifiers

PMID33521866
PMCPMC7987708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.